Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry.
Masayoshi HarigaiEiichi TanakaEisuke InoueRyoko SakaiNaohiro SugitaniShigeyuki ToyoizumiNaonobu SugiyamaHisashi YamanakaPublished in: Rheumatology and therapy (2024)
The use of bDMARDs was not a time-dependent risk factor for malignancy.